Skip to main content
. 2022 Feb 8;20:32. doi: 10.1186/s12957-021-02477-y

Fig. 3.

Fig. 3

A Proliferation assay of the Con, sh-TMED2, and control-shTMED2 group after 4 days of treatment. B PI-Hoechst staining assay (× 800) and C quantification of PI(+) cells. D Western blot assay of TMED2, CEA, NSE, and EGFR expression in vitro. E Quantification of CEA, NSE, and EGFR expression. Protein levels were normalized to β-actin. (sh-TMED2 vs. other groups, *P < 0.05, n = 6 per group)